Your session is about to expire
← Back to Search
Bereavement Support Program for Grief
N/A
Waitlist Available
Led By Marina Ivanyuk, MD
Research Sponsored by New York City Health and Hospitals Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial aims to help caregivers cope with loss by providing a program to reduce the chance of long-term grief.
Who is the study for?
This trial is for informal caregivers, aged 18 or older, who are looking after patients receiving end-of-life care from Palliative Care services in a hospital. Participants must speak English. It's not suitable for those caring outside of these settings.Check my eligibility
What is being tested?
The study tests a bereavement support program that uses vocal expression and cognitive behavioral techniques to help caregivers cope with grief after the loss of their loved ones.See study design
What are the potential side effects?
Since this trial involves emotional and psychological support rather than medical treatments, side effects may include emotional discomfort or distress during sessions but no physical side effects are expected.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Bereavement Experience Questionnaire (BEQ-24) from Baseline
Secondary outcome measures
Change in Patient Health Questionnaire-9 from Baseline
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive BehavioralExperimental Treatment1 Intervention
Cognitive-behavioral techniques with sessions consisting of approximately 20-30 minutes.
Group II: Vocal ExpressionActive Control1 Intervention
Supportive care through vocal expression sessions where participants can talk for approximately 20-30 minutes about the person who died.
Find a Location
Who is running the clinical trial?
New York City Health and Hospitals CorporationLead Sponsor
32 Previous Clinical Trials
8,423 Total Patients Enrolled
Marina Ivanyuk, MDPrincipal InvestigatorNew York City Health and Hospitals Corporation
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a caregiver or under 18 years old.I am over 18 and care for someone who is also over 18.I am currently in the hospital or emergency department and have been referred to end-of-life care.I have a court-appointed guardian.I am a caregiver without panic attack symptoms.
Research Study Groups:
This trial has the following groups:- Group 1: Vocal Expression
- Group 2: Cognitive Behavioral
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are researchers still enrolling for this research project?
"The medical trial in question is not actively enrolling patients according to the clinicaltrials.gov records, which were last updated on April 21st 2023. However, there are 6 other trials searching for participants at this time."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger